Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2025 08:00 ET | Source: Chemomab Therapeutics

Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences

Clinical data on Chemomab's nebokitug for the treatment of PSC will be presented at the scientific conferences DDW25; EASL 2025 and BSG LIVE'25
April 15, 2025 08:00 ET | Source: Chemomab Therapeutics

Chemomab Announces New Medical and Clinical Appointments

David Weiner, MD, is rejoining Chemomab as Interim Chief Medical Officer and Clinical Development SVP Jack Lawler has been named Chief Development Officer.